Skip to search.
 TSX Up 0.10% TSX Ventures Down 0.27%

XOMA Corporation (XOMA)

-NasdaqGM
3.60 Down 0.02(0.55%) 4:00PM EDT
|After Hours : 3.61 Up 0.01 (0.28%) 4:00PM EDT
Add to Portfolio
Prev Close:3.62
Open:3.64
Bid:3.60 x 1400
Ask:3.75 x 3100
1y Target Est:8.71
Beta:3.54
Earnings Date:May 4 - May 10 (Est.)
Day's Range:3.59 - 3.72
52wk Range:3.22 - 5.95
Volume:1,157,715
Avg Vol (3m):2,107,820
Market Cap:420.98M
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
XOMADown 0.55%420.98M
NVSDown 1.16%250.13B
REGNUp 0.00%49.58B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.29
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.59
Quarterly EPS Est (Mar-15) :-0.16
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.32

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

XOMA Corporation discovers and develops antibody-based therapeutics in the United States, Europe, and the Asia Pacific. The company’s lead product candidate includes gevokizumab, a proprietary humanized allosteric-modulating monoclonal antibo... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback